BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24961918)

  • 1. Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teams.
    Woolf EJ; McDougall S; Fast DM; Andraus M; Barfield M; Blackburn M; Gordon B; Hoffman D; Inoue N; Marcelin-Jimenez G; Flynn A; LeLacheur R; Reuschel S; Santhanam R; Bennett P; Duncan B; Hayes R; Lausecker B; Sharma A; Togashi K; Trivedi RK; Vago M; White S; Barton H; Dunn JA; Farmen RH; Heinig K; Holliman C; Komaba J; Riccio MF; Thomas E;
    AAPS J; 2014 Sep; 16(5):885-93. PubMed ID: 24961918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization team.
    Lowes S; Hucker R; Jemal M; Marini JC; Rezende VM; Shoup R; Singhal P; Timmerman P; Yoneyama T; Weng N; Zimmer D
    AAPS J; 2015 Jan; 17(1):17-23. PubMed ID: 25338740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method transfer, partial validation, and cross validation: recommendations for best practices and harmonization from the global bioanalysis consortium harmonization team.
    Briggs RJ; Nicholson R; Vazvaei F; Busch J; Mabuchi M; Mahesh KS; Brudny-Kloeppel M; Weng N; Galvinas PA; Duchene P; Hu P; Abbott RW
    AAPS J; 2014 Nov; 16(6):1143-8. PubMed ID: 25190270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal standard response variations during incurred sample analysis by LC-MS/MS: Case by case trouble-shooting.
    Tan A; Hussain S; Musuku A; Massé R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3201-9. PubMed ID: 19733134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team.
    Kelley M; Beaver C; Stevenson LF; Bamford R; Gegwich P; Katsuhiko Y; Li D; Little S; Muruganandam A; Stoellner D; Trivedi RK
    AAPS J; 2014 Mar; 16(2):221-5. PubMed ID: 24395373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis.
    Fu Y; Barkley D; Li W; Picard F; Flarakos J
    Bioanalysis; 2020 Apr; 12(8):545-559. PubMed ID: 32352315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
    Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
    J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers-accelerator mass spectrometry (AMS): Recommendation for best practices and harmonization from Global Bioanalysis Consortium Harmonization Team.
    Young GC; Seymour M; Dueker SR; Timmerman P; Arjomand A; Nozawa K
    AAPS J; 2014 Mar; 16(2):357-9. PubMed ID: 24500278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat analysis and incurred sample reanalysis: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.
    Fluhler E; Vazvaei F; Singhal P; Vinck P; Li W; Bhatt J; de Boer T; Chaudhary A; Tangiuchi M; Rezende V; Zhong D
    AAPS J; 2014 Nov; 16(6):1167-74. PubMed ID: 25135836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmonization of Liquid Chromatography-Tandem Mass Spectrometry Protein Assays.
    Rockwood AL; Lowenthal MS; Bystrom C
    Clin Lab Med; 2018 Sep; 38(3):499-513. PubMed ID: 30115394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
    Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
    Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics.
    Jenkins R; Duggan JX; Aubry AF; Zeng J; Lee JW; Cojocaru L; Dufield D; Garofolo F; Kaur S; Schultz GA; Xu K; Yang Z; Yu J; Zhang YJ; Vazvaei F
    AAPS J; 2015 Jan; 17(1):1-16. PubMed ID: 25392238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review.
    Cortese M; Gigliobianco MR; Magnoni F; Censi R; Di Martino PD
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32635301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconsistent internal standard response in LC-MS/MS bioanalysis: an evaluation of case studies.
    Fraier D; Ferrari L; Heinig K; Zwanziger E
    Bioanalysis; 2019 Sep; 11(18):1657-1667. PubMed ID: 31556309
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated non-stepwise preparation of bioanalytical calibration standards and quality controls using an ultra-low volume digitizing liquid dispenser.
    Liao D; Chen S; Paton M; Qian MG
    Rapid Commun Mass Spectrom; 2014 Jun; 28(11):1215-20. PubMed ID: 24760562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a serum total testosterone liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay calibrated to NIST SRM 971.
    French D
    Clin Chim Acta; 2013 Jan; 415():109-17. PubMed ID: 23085208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of using highly pure internal standards for successful liquid chromatography/tandem mass spectrometric bioanalytical assays.
    Bergeron A; Furtado M; Garofolo F
    Rapid Commun Mass Spectrom; 2009 May; 23(9):1287-97. PubMed ID: 19308966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special Considerations for Liquid Chromatography-Tandem Mass Spectrometry Method Development.
    Rappold BA
    Clin Lab Med; 2018 Sep; 38(3):539-551. PubMed ID: 30115397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
    Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
    J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking.
    Young BL; Cooks RG; Madden MC; Bair M; Jia J; Aubry AF; Miller SA
    J Pharm Biomed Anal; 2007 Apr; 43(5):1602-8. PubMed ID: 17298872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.